Teleflex (TFX) Retained Earnings (2009 - 2025)
Teleflex's (TFX) quarterly Retained Earnings came in at $3.1 billion in Q4 2025, down 23.47% on a YoY basis from $4.1 billion in Q4 2024, and down 23.47% quarter-over-quarter from $4.1 billion in Q4 2024.
Analysis
Teleflex (TFX) Retained Earnings (2009 - 2025) Analysis & Trends
Teleflex (TFX) has reported Retained Earnings for 17 consecutive years, with $3.1 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 23.47% year-over-year to $3.1 billion; the trailing twelve-month figure through Dec 2025 stood at $3.1 billion (down 23.47% YoY), and the FY2025 full-year result was $3.1 billion, down 23.47% from the prior year.
- Retained Earnings fell to $3.1 billion in Q4 2025 per TFX's latest filing, from $4.1 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $4.1 billion in Q4 2024 and bottomed at $3.1 billion in Q4 2025.
- Historically, Retained Earnings has averaged $3.7 billion across 5 years, with a median of $3.8 billion in 2022.
- The sharpest annual moves came in 2021 and 2025: Retained Earnings rose 13.62% in 2021, then retreated 23.47% in 2025.
- Over 5 years, Retained Earnings stood at $3.5 billion in 2021, then climbed by 8.51% to $3.8 billion in 2022, then advanced by 7.66% to $4.1 billion in 2023, then rose by 0.15% to $4.1 billion in 2024, then declined by 23.47% to $3.1 billion in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered $3.1 billion, $4.1 billion, and $4.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Teleflex | 5.76 Bn | 5.46 Bn | 331.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.15 Bn |
| Dec 31, 2024 | 4.12 Bn |
| Dec 31, 2023 | 4.11 Bn |
| Dec 31, 2022 | 3.82 Bn |
| Dec 31, 2021 | 3.52 Bn |
| Dec 31, 2020 | 3.10 Bn |
| Dec 31, 2019 | 2.82 Bn |
| Dec 31, 2018 | 2.43 Bn |
| Dec 31, 2017 | 2.29 Bn |
| Dec 31, 2016 | 2.19 Bn |
| Dec 31, 2015 | 2.02 Bn |
| Dec 31, 2014 | -260.90 Mn |
| Dec 31, 2013 | -110.86 Mn |
| Dec 31, 2012 | -132.05 Mn |
| Dec 31, 2011 | -159.35 Mn |
| Dec 31, 2010 | -51.88 Mn |
| Dec 31, 2009 | 1.43 Bn |